Matthias Bodenstedt, CFO of MoonLake Immunotherapeutics ($MLTX), made one open market purchase of company shares in the last year, totaling nearly $99,000, with the most recent on October 8, 2025. He ranks 2,375th among 4,983 insiders for purchase volume, below the average of $1.5 million across 3.29 transactions per insider. Bodenstedt had no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | MoonLake Immunotherapeutics | $MLTX | Bodenstedt Matthias | Chief Financial Officer | A | Class A ordinary shares, par value $0.0001 per share | 354296 | $0.00 | 1,276,305.0000 | 64,037,478 | 38.43% | 0.55% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Bodenstedt Matthias | Chief Financial Officer | C | Class A ordinary shares, par value $0.0001 per share | 294473 | $0.00 | 922,009.0000 | 64,037,478 | 46.93% | 0.46% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Bodenstedt Matthias | Chief Financial Officer | D | Class C ordinary shares, par value $0.0001 per share | 294473 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.46% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Bodenstedt Matthias | Chief Financial Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 8754 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.01% |
| Oct. 8, 2025 | MoonLake Immunotherapeutics | $MLTX | Bodenstedt Matthias | Chief Financial Officer | P | Class A ordinary shares, par value $0.0001 per share | 10870 | $9.09 | 627,536.0000 | 64,037,478 | 1.76% | 0.02% |
| Feb. 27, 2025 | MoonLake Immunotherapeutics | $MLTX | Bodenstedt Matthias | Chief Financial Officer | A | Class A ordinary shares, par value $0.0001 per share | 95763 | $0.00 | 616,666.0000 | 62,870,237 | 18.38% | 0.15% |